---
$id: https://graph.org.ai/products/commodity/51303205
$type: Product
source: UNSPSC
code: "51303205"
title: "Tolindate"
class: "51303200"
classTitle: "Antifungals, synthesized"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tolindate

**UNSPSC Code**: 51303205
**Class**: [Antifungals, synthesized](Antifungals, synthesized.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5236RK32KG. European Medicines Agency schedules Tolindate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11158MIG. Tolindate generally arises in the molecular formula C18H19NOS. The term TOLINDATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, no. 10 1973, list 13.) TOLINDATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tolindate under HS 29302000 and SITC 51542. As of Q4 2014, TOLINDATE remains the US FDA Preferred Term for this commodity. Tolindate bears US NLM identifiers UMLS ID C2827341 and NCI Concept Code C84218. SMILES: S=C(OC1CC2CCCC2CC1)N(C1CC(CCC1)C)C.

